| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 3 Jun 2026 | 3 Jun 2026 |
| Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors of the Company, at its meeting held today, i.e., June 03, 2026, has, inter-alia, considered and approved credit facilities from HDFC Bank Limited aggregating to Rs. 91.31 Crores and execution of the necessary loan, security and ancillary documents, including creation of security in favour of the Bank, in accordance with the terms of the sanction letter. | ||
| Board Meeting | 20 May 2026 | 12 May 2026 |
| Qualitek Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/05/2026 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the meeting of the Board of Directors of the Company is scheduled on Friday, May 15, 2026, inter alia, to consider and approve 1. Audited standalone and consolidated Financial results for the half year and financial year ended 31.03.2026 2. Any Other agenda items Qualitek Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2026 ,inter alia, to consider and approve Audited Financial Results (Standalone and Consolidated) of the Company for the half year and financial year ended March 31, 2026; together with the Auditors Report thereon by the Statutory Auditor of the Company as per Regulation 33 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 and others. (As per BSE Announcement dated on: 15.05.2026) In terms of Regulations 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of Qualitek Labs Limited (the Company) at its meeting held on Wednesday, May 20, 2026, inter-alia, considered and approved Audited Financial Results (Standalone and Consolidated) of the Company for the half year and financial year ended March 31, 2026, along with the Auditors Report thereon issued by the Statutory Auditors of the Company. (As Per BSE Announcement Dated on:20.05.2026) | ||
| Board Meeting | 20 Apr 2026 | 20 Apr 2026 |
| Pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015, we hereby inform you that the Board of Directors of the Company, at its meeting held today, i.e., April 20, 2026, has, inter alia, considered and approved the following: (i) The appointment of Mr. Mohit Kumar as Company Secretary and Compliance Officer (Key Managerial Personnel) of the Company with effect from April 20, 2026. (ii) Pursuant to Regulation 30(5) of the SEBI (LODR) Regulations, 2015, the Board of Directors has amended the authorization for determining the materiality of an event or information and for the purpose of making disclosures to the stock exchange(s) under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. | ||
| Board Meeting | 20 Dec 2025 | 17 Dec 2025 |
| Qualitek Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/12/2025 inter alia to consider and approve issuance of NCDs creation of security/guarantees appointment of Debenture Trustee and convening of EGM. Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board of Directors of Qualitek Labs Limited at its meeting held on 20th December, 2025 approved the issuance of secured, unlisted, redeemable non-convertible debentures aggregating up to ?65 crore on a private placement basis, appointment of Vistra ITCL (India) Limited as Debenture Trustee, creation of security and furnishing of guarantees in connection therewith, and convening of an Extraordinary General Meeting to seek requisite shareholder approvals. The Company shall make further disclosures as and when required under SEBI LODR Regulations. (As per BSE Announcement dated on: 20.12.2025) | ||
| Board Meeting | 10 Dec 2025 | 11 Dec 2025 |
| As per the attached information | ||
| Board Meeting | 12 Nov 2025 | 3 Nov 2025 |
| Qualitek Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2025 inter alia to consider and approve the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter and half year ended 30th September 2025. Limited Review Report along with Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter and half year ended September 30, 2025 (As Per BSE Announcement Dated on: 12/11/2025) | ||
| Board Meeting | 10 Sep 2025 | 6 Sep 2025 |
| Qualitek Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/09/2025 inter alia to consider and approve the allotment of 1672531 equity shares of ?10 each at ?310.89 per share on a preferential basis to the shareholders of Interstellar Testing Centre Private Limited through a share swap. This allotment is proposed pursuant to the special resolution passed on 25/06/2025 and the in-principle approval granted by BSE on 04/09/2025 for allotment to both Promoters and Non-Promoters As per the attached information (As Per BSE Announcement Dated on 10.09.2025) | ||
| Board Meeting | 29 Aug 2025 | 29 Aug 2025 |
| Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, we wish to inform that the Board of Directors of Qualitek Labs Limited, at its meeting held on Friday, 29th August, 2025, inter-alia, considered and approved various matters. The detailed outcome of the meeting is attached herewith. | ||
| Board Meeting | 5 Jul 2025 | 5 Jul 2025 |
| Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board of Directors considered and approved the 1) Issuance of Corporate Guarantee, 2) Acceptance of Credit Facility from Kotak Mahindra Bank Limited, and 3) Acceptance of Credit Facility and creation of Charge in favor of HDFC Bank Limited. | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
